METASTATIC INVASIVE LOBULAR CARCINOMA

Clinical trials for METASTATIC INVASIVE LOBULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC INVASIVE LOBULAR CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC INVASIVE LOBULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Terminated trial tests new hope for Tough-to-Treat breast cancer

Disease control Terminated

This study aimed to see if a drug called repotrectinib, given with or without another drug called fulvestrant, could help control metastatic lobular breast cancer in people whose cancer had progressed after standard hormone-based treatments. It was a Phase 2 trial that enrolled o…

Matched conditions: METASTATIC INVASIVE LOBULAR CARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

METASTATIC INVASIVE LOBULAR CARCINOMA

Get alerted when new METASTATIC INVASIVE LOBULAR CARCINOMA trials appear

Terminated trial tests new hope for Tough-to-Treat breast cancer